Overcoming challenges regarding reference materials and regulations that influence global standardization of medical laboratory testing results

Author:

Miller W. Greg1,Myers Gary2,Cobbaert Christa M.3,Young Ian S.4,Theodorsson Elvar5,Wielgosz Robert I.6,Westwood Steven6,Maniguet Stephanie6,Gillery Philippe7

Affiliation:

1. Department of Pathology , Virginia Commonwealth University , Richmond , VA , USA

2. Myers Consulting , Smyrna , GA , USA

3. Department of Clinical Chemistry and Laboratory Medicine , Leiden University Medical Centre , Leiden , The Netherlands

4. Centre for Public Health, Queens University Belfast , Belfast , Northern Ireland

5. Department of Biomedical and Clinical Science, Clinical Chemistry , Linköping University , Linköping , Sweden

6. Bureau International des Poids et Mesures (BIPM) , Sèvres Cedex , France

7. Laboratory of Biochemistry-Pharmacology-Toxicology, University Hospital of Reims , Reims , France

Abstract

Abstract Background Standardized results for laboratory tests are particularly important when their interpretation depends on fixed medical practice guidelines or common reference intervals. The medical laboratory community has developed a roadmap for an infrastructure to achieve standardized test results described in the International Organization for Standardization standard 17511:2020 In vitro diagnostic medical devices – Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples. Among the challenges to implementing metrological traceability are the availability of fit-for-purpose matrix-based certified reference materials (CRMs) and requirements for regulatory review that differ among countries. A workshop in December 2021 focused on these two challenges and developed recommendations for improved practices. Discussion The participants agreed that prioritization of measurands for standardization should be based on their impact on medical decisions in a clinical pathway. Ensuring that matrix-based CRMs are globally available for more measurands will enable fit-for-purpose calibration hierarchies for more laboratory tests. Regulation of laboratory tests is important to ensure safety and effectiveness for the populations served. Because regulations are country or region specific, manufacturers must submit recalibration changes intended to standardize results for regulatory review to all areas in which a measuring system is marketed. Recommendations A standardization initiative requires collaboration and planning among all interested stakeholders. Global collaboration should be further developed for prioritization of measurands for standardization, and for coordinating the production and supply of CRMs worldwide. More uniform regulatory submission requirements are desirable when recalibration is implemented to achieve internationally standardized results.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Reference31 articles.

1. Hallworth, MJ, Epner, PL, Ebert, C, Fantz, CR, Faye, SA, Higgins, TN, et al.. Current evidence and future perspectives on the effective practice of patient-centered laboratory medicine. Clin Chem 2015;61:589–99. https://doi.org/10.1373/clinchem.2014.232629.

2. Ngo, A, Gandhi, P, Miller, WG. Frequency that laboratory tests influence medical decisions. J Applied Lab Med 2017;1:410–4. https://doi.org/10.1373/jalm.2016.021634.

3. Horvath, AR, Lord, SJ, St John, A, Sandberg, S, Cobbaert, CM, Lorenz, S, et al.. From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta 2014;427:49–57. https://doi.org/10.1016/j.cca.2013.09.018.

4. ISO 17511:2020. In vitro diagnostic medical devices – requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples. Geneva, Switzerland: International Organization for Standardization; 2020.

5. Database of higher-order reference materials, measurement methods/procedures and services, Joint Committee of Traceability In Laboratory Medicine. https://www.bipm.org/jctlm/ [Accessed 21 Oct 2022].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3